Near-infrared laser adjuvant for mass vaccination

Satoshi Kashiwagi

doi:10.1117/12.2583904

5 March 2021 Near-infrared laser adjuvant for mass vaccination

Satoshi Kashiwagi

Proceedings Volume 11643, Biophotonics and Immune Responses XVI; 116430E (2021) https://doi.org/10.1117/12.2583904
Event: SPIE BiOS, 2021, Online Only

Abstract

The incorporation of an immunologic adjuvant to enhance the immune response is a standard practice for modern vaccines. In the past decade, researchers have consistently reported a new approach to augment the immune response to vaccine by brief treatment of the skin with laser light without appreciable adverse effects. To date, four classes of laser adjuvant have been established. Amongst these, pulsed and non-pulsed laser adjuvant merit further development because of their established efficacy and safety in animal models. Such a technology offers a valuable choice of immunologic adjuvant for accelerated vaccine development against emerging infectious diseases including COVID-19.

Conference Presentation

Citation Download Citation

Satoshi Kashiwagi "Near-infrared laser adjuvant for mass vaccination", Proc. SPIE 11643, Biophotonics and Immune Responses XVI, 116430E (5 March 2021); https://doi.org/10.1117/12.2583904

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available